J. Watanabe

发表

Expression of Cell Cycle Regulators in Endometrial Adenocarcinoma

H. Kuramoto, J. Watanabe, Y. Kamata, 2003 .

PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus

H. Kuramoto, J. Watanabe, Y. Kamata, 2004, Journal of Cancer Research and Clinical Oncology.

Paradoxical expression of cell cycle inhibitor p27 in endometrioid adenocarcinoma of the uterine corpus – correlation with proliferation and clinicopathological parameters

E. Ohno, H. Kuramoto, H. Sato, 2002, British Journal of Cancer.

Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables

H. Kuramoto, J. Watanabe, T. Jobo, 2002, Journal of Cancer Research and Clinical Oncology.

Immunohistochemical expression of cyclin E in endometrial adenocarcinoma (endometrioid type) and its clinicopathological significance

H. Kuramoto, J. Watanabe, Y. Kamata, 2003, Journal of Cancer Research and Clinical Oncology.

Liquid‐based preparation for endometrial cytology—Usefulness for predicting the prognosis of endometrial carcinoma preoperatively

H. Kuramoto, I. Okayasu, J. Watanabe, 2009, Cancer.

Adequacy evaluation of endometrial cytology using Thinlayer specimens

M. Hattori, I. Okayasu, J. Watanabe, 2008 .

Angiopoietin-1, 2 and Tie2 expressions in endometrial adenocarcinoma--the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF.

H. Kuramoto, J. Watanabe, Y. Kamata, 2006, European journal of gynaecological oncology.

Significance of p27 as a predicting marker for medroxyprogesterone acetate therapy against endometrial endometrioid adenocarcinoma

H. Kuramoto, I. Okayasu, J. Watanabe, 2005, International Journal of Gynecologic Cancer.

Neuroendocrine features in poorly differentiated endometrioid adenocarcinomas of the endometrium

H. Kuramoto, J. Watanabe, T. Kanai, 2005, International Journal of Gynecologic Cancer.

Differential Diagnosis of Reactive Mesothelial Cells and Malignant Mesothelioma Cells Using the Cell Proliferation Markers Minichromosome Maintenance Protein 7, Geminin, Topoisomerase II Alpha and Ki-67

M. Saegusa, I. Okayasu, J. Watanabe, 2013, Acta Cytologica.

Angiogenic factors in normal endometrium and endometrial adenocarcinoma

H. Kuramoto, Yuichi Sato, J. Watanabe, 2007, Pathology international.

Isoflavones regulate secretion of leukemia inhibitory factor and transforming growth factor {beta} and expression of glycodelin in human endometrial epithelial cells.

Y. Yamori, J. Watanabe, A. Yanaihara, 2008, The Journal of endocrinology.

Isoflavones regulate secretion of leukemia inhibitory factor and transforming growth factor β and expression of glycodelin in human endometrial epithelial cells

J. Watanabe, A. Yanaihara, K. Ikeda, 2007 .

Role of Estrogen and Estrogen-Related Growth Factor in the Mechanism of Hormone Dependency of Endometrial Carcinoma Cells

H. Kuramoto, J. Watanabe, M. Hamano, 1998, Oncology.

Significance of Matrix Metalloproteinase-2, -11 and Tissue Inhibitor of Metalloproteinase-1 Expression in Normal, Hyperplastic and Neoplastic Endometrium

H. Kuramoto, J. Watanabe, Y. Nishimura, 2007 .

Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases

H. Kuramoto, J. Watanabe, T. Kanai, 2004, International Journal of Gynecologic Cancer.

Significance of cell proliferation markers (Minichromosome maintenance protein 7, topoisomerase IIα and Ki‐67) in cavital fluid cytology: Can we differentiate reactive mesothelial cells from malignant cells?

I. Okayasu, J. Watanabe, K. Kawai, 2009, Diagnostic cytopathology.

Expression of Tumor Suppressor Gene Product p14ARF in Endometrioid Adenocarcinoma of the Uterine Corpus

H. Kuramoto, I. Okayasu, J. Watanabe, 2004, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Cyclin D1 expression in endometrioid-type endometrial adenocarcinoma is correlated with histological grade and proliferative activity, but not with prognosis.

H. Kuramoto, J. Watanabe, Y. Kamata, 2004, Anticancer research.

Expression of nm23-H1 and nm23-H2 protein in endometrial carcinoma.

H. Kuramoto, T. Kameya, J. Watanabe, 1995, British Journal of Cancer.

Clear cell adenocarcinoma of the endometrium is a biologically distinct entity from endometrioid adenocarcinoma

H. Kuramoto, J. Watanabe, Y. Kamata, 2004, International Journal of Gynecologic Cancer.

Stimulatory effect of estrogen on the growth of endometrial cancer cells is regulated by cell-cycle regulators

H. Kuramoto, I. Okayasu, J. Watanabe, 2007, The Journal of Steroid Biochemistry and Molecular Biology.

Effects of serine and glycine on proliferation of an Ishikawa cell variant.

H. Kuramoto, J. Watanabe, E. Gurpide, 1989, Journal of steroid biochemistry.

Basement Membrane–like Substance in Cytologic Diagnosis in Clear Cell Adenocarcinoma of the Minor Salivary Gland of the Palate

M. Hattori, H. Kuramoto, K. Iwabuchi, 2007, Acta Cytologica.

Coexisting clear cell adenocarcinoma and squamous cell carcinoma arising from ovarian endometriosis

H. Kuramoto, J. Watanabe, T. Jobo, 2000, International Journal of Clinical Oncology.

VEGF expression and its reguration by p53 gene transfection in endometrial carcinoma cells

H. Kuramoto, J. Watanabe, Y. Kamata, 2003, Human Cell.

Effect of p53 gene transfection on vascular endothelial growth factor expression in endometrial cancer cells.

H. Kuramoto, J. Watanabe, Y. Kamata, 2003, Experimental and molecular pathology.

Transcription factor Egr1 acts as an upstream regulator of β‐catenin signalling through up‐regulation of TCF4 and p300 expression during trans‐differentiation of endometrial carcinoma cells

M. Saegusa, I. Okayasu, J. Watanabe, 2008, The Journal of pathology.

CYTOLOGIC SCORING OF ENDOMETRIOID ADENOCARCINOMA OF THE ENDOMETRIUM

M. Hattori, H. Kuramoto, J. Watanabe, 2004, International Journal of Gynecologic Cancer.

Androgen‐Producing Ovarian Tumors: A Clinicopathological Study of 3 Cases

E. Ohno, J. Watanabe, M. Arai, 1999, The journal of obstetrics and gynaecology research.

Qualitative and Quantitative Assessment of Modified In Situ Reverse Transcription-Polymerase Chain Reaction (In Situ RT-PCR) Method

H. Kuramoto, Yuichi Sato, J. Watanabe, 1999 .

Significance of progesterone receptor-A and -B expressions in endometrial adenocarcinoma

M. Hattori, H. Kuramoto, J. Watanabe, 2004, The Journal of Steroid Biochemistry and Molecular Biology.

Concomitant expression of HER2 and HIF-1alpha is a predictor of poor prognosis in uterine cervical carcinoma treated with concurrent chemoradiotherapy: prospective analysis (KGROG0501).

K. Matsuo, Y. Niibe, J. Watanabe, 2010, European journal of gynaecological oncology.

Concomitant Expression of HER2 and HIF-1 is a Poor Prognostic Factor in Uterine Cervical Carcinoma Treated with Concurrent Chemoradiotherapy: Prospective Analysis (KGROG0501)

K. Matsuo, Y. Niibe, J. Watanabe, 2008 .

[Clinical significance of CA19-9 for endometriosis].

H. Kuramoto, J. Watanabe, H. Hata, 1990, Nihon Sanka Fujinka Gakkai zasshi.

Significance of Nuclear p-Akt in Endometrial Carcinogenesis: Rapid Translocation of p-Akt Into the Nucleus by Estrogen, Possibly Resulting in Inhibition of Apoptosis

H. Kuramoto, I. Okayasu, J. Watanabe, 2010, International Journal of Gynecologic Cancer.

Lymph node pathway in the spread of endometrial carcinoma.

H. Kuramoto, J. Watanabe, T. Jobo, 2005, European journal of gynaecological oncology.

Establishment and characterization of two cell lines (HEC-155, HEC-180) derived from uterine papillary serous adenocarcinoma.

H. Kuramoto, J. Watanabe, Y. Nishimura, 2004, European journal of gynaecological oncology.

Up‐regulation and nuclear localization of β‐catenin in endometrial carcinoma in response to progesterone therapy

H. Kuramoto, M. Saegusa, Tsutomu Yoshida, 2003, Cancer science.

Clinical Significance of Human Papillomavirus Genotype by Linear Array Assay in Japanese Women With Uterine Cervical Lesions and Type 16 Physical Status by In Situ Hybridization

I. Okayasu, J. Watanabe, Y. Nishimura, 2009, International Journal of Gynecologic Cancer.

Small-cell carcinoma of the uterine cervix: a clinicopathologic study of 11 cases

H. Kuramoto, J. Watanabe, T. Kanai, 2004, International Journal of Gynecologic Cancer.

Effects of Hormones on Endometrial Cancer Cells in Culture

H. Kuramoto, J. Watanabe, H. Hata, 1991, Annals of the New York Academy of Sciences.

Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.

H. Kuramoto, J. Watanabe, Y. Nishimura, 2007, Anticancer research.

Immunohistochemical study on VEGF expression in endometrial carcinoma – comparison with p53 expression, angiogenesis, and tumor histologic grade

E. Ohno, H. Kuramoto, J. Watanabe, 2001, Journal of Cancer Research and Clinical Oncology.